Posts Tagged MK-0524A

FDA Tells Merck “NO” — Twice Burned, Twice Shy?

A few weeks ago, the FDA refused Merck Pharmaceuticals permission to sell a newly developed drug called MK-0524A  that combines niacin and a cholesterol drug . Today we learn that Merck has now stopped trials of the drug. As you know if you read this blog or my other blogs regularly, Merck has been caught […]

Continue Reading →

Posted in: Health /Medical Consumerism, Healthcare Quality, Medical and Research Studies, Patient Advocacy, Patient Empowerment, Patient Safety

Leave a Comment (0) →